【AGER（Advanced glycosylation end product-specific receptor）晚期糖基化終末產(chǎn)物特異性受體(抗原）】齊一生物專業(yè)代理Sigma西格瑪.美國BD.賽默飛.日本wako.TCL.默克Merck .美國AMRESCO.日本榮研化學(xué)株式會社.EP（歐洲藥典）.USP（美國藥典）.BP（英國藥典）加拿大TRC等試劑.標(biāo)準(zhǔn)品.對照品齊一生物銷售：021－6034 8496；181214 53965；173021 04490網(wǎng)站：www.qiyibio.com【AGER（Advanced glycosylation end product-specific receptor）晚期糖基化終末產(chǎn)物特異性受體(抗原）】

337620    qBiomarker SYBR Green Fluor Mastermix(2)             CNY                           

337011    qBiomarker Somatic Mutations PCR Assays        CNY                           

4500263  artus HSV-1/2 RG PCR Kit (24) CE             CNY                           

939016    Buffer ATL ( 4 x 50 ml),GPR        CNY                           

4500163  artus HSV-1/2 TM PCR Kit (24) CE            CNY                           

1073925  Ni-NTA Superflow (8 x 500 ml),cus,G        CNY                           

9010931  BGR Greifer P7 (alt)             CNY                           

9010858  BGR DT-Abstreifer 8-fach P7xxx D            CNY                           

931036    QIAsymphony Virus/Bact Mini Kit (192)             CNY                           

133248    NeXtalStock Sodium succinate pH6.5 (200)        CNY                            【AGER（Advanced glycosylation end product-specific receptor）晚期糖基化終末產(chǎn)物特異性受體(抗原）】

330603    RT² SYBR Green FAST Mastermix (24)              CNY                           

929608    QX Pro Separation Buffer (40 ml)        CNY                           

5000-1415      Knob RB671CSKWL Matte, VTX2              CNY                           

5000-1408      Cable Shielded 1/17HP, VTX2              CNY                           

L2170     hc2 CT/GC HC2 DNA Test PI (CD-ROM)          CNY                           

L1971     Rotary Shaker User＇s Manual        CNY                           

9240705  O-ring Kit, Capper, Spindle, AP            CNY                           

9240693  Actril Sterilant & Test Strips, AP          CNY                           

9243653  Comprehen Valid., Other Extraction Sys       """The Comprehensive Validation Support plan specific to a laboratory＇s needs will incorporate all of the requirements for the internal validation guidelines from the FBI＇s Quality Assurance Standards (QAS).

The Comprehensive Validation Support service includes all travel ａnd labor charges for up to 20 days by the QIAGEN Validation Team. Typically, one week will be required to extract, quantify, ａnd amplify the validation study samples ａnd may require multiple individuals. Usually, two weeks is required to analyze the data ａnd one week to write the final report. The expected time period to complete the Comprehensive Validation is six weeks. The actual time may vary depending on resource availability, including laboratory time dedicated to validation activities.

Lab Work – The QIAGEN specialist(s) will travel to the laboratory to conduct the on-site validation lab work. The QIAGEN specialist team will perform ａnd complete all extractions, quantifications, amplfications, ａnd capillary electrophoresis. The laboratory is responsible for providing systems/protocols that may be needed (generally laboratory SOPs, ex. interpretation guidelines). Additionally, the laboratory staff may be required to provide additional data needed for interpretation (ex. quantification/amplification/CE results) during the data review phase of the validation.

Once the final scope of the validation is determined, QIAGEN will provide a quote for all consumables required for the validation.  Non-QIAGEN chemistry ａnd accessories are not included ａnd should  be purchased to cover the validation experimental design including qPCR, STR, NIST standards, required samples types (blood, semen, buccal samples) ａnd required substrates (swabs, materials, etc).   The Customer is expected to have all materials on-hand 1 week prior to the validation start date.

Data Analysis – The Comprehensive Validation Support plan encompasses data collection (quants, amps, CE) during the on-site visit. The laboratory may be responsible for sharing (typically electronically via e-mail) any validation data requested after the on-site visit. A QIAGEN specialist will complete all of the data analysis produced from the validation study design. This includes qPCR (quant) ａnd STR (amp) analysis ａnd linkage to starting samples.

Validation data CD/flashdrive – QIAGEN will review the validation data ａnd draft a validation summary document, ensuring compliance with the FBI＇s QAS requirements/standards. QIAGEN will send validation data in an electronic format (email/CD/flashdrive) to the laboratory. The laboratory is responsible for final compilation, any format change preferences, review ａnd signoff of the validation report. The documentation provided by QIAGEN will aide in demonstrating compliance with all accreditation guidelines during laboratory audits. Should a hard copy of the validation study be preferred, the laboratory is required to specify prior to the onset of the validation.

Post-validation QIAGEN-to-Laboratory Transfer – Following completion of the validation ａnd generation of the draft validation summary document, a designated member of the QIAGEN validation team will review the validation with the Lab Manager ａnd the Technical Leader. Following sign off on the validation report, training of the laboratory DNA staff will occur. Refer to the Post-validation Competency Training for additional information. """   CNY                           

386516    Investigator STR GO! Lysis Buffer (200)            CNY                           

208256    QuantiNova Probe PCR Kit (2500)              CNY                           

208254    QuantiNova Probe PCR Kit (500)         CNY                           

180984    GeneRead Adapter I Set 12plex (72)            CNY                           

614035    careHPV Test, SFDA (96-test)             CNY                           

282605    virotype Influenza A RT-PCR Kit (96)          CNY                           

272703    pigtype PRRSV Ab (5)          CNY                            【AGER（Advanced glycosylation end product-specific receptor）晚期糖基化終末產(chǎn)物特異性受體(抗原）】

273003    pigtype Salmonella Ab (5)             CNY                           

QY-03250       GAD-65 (glutamate decarboxylase)谷氨酸脫羧酶-65(抗原)              0.5mg/8501mg/1300                         

QY-01540       GAP-43 ( Growth associated protein-43 )生長相關(guān)蛋白-43（抗原）              0.5mg/6501mg/1100                         

QY-00100       Gastrin胃泌素（抗原）               0.5mg/6501mg/1100                         

QY-01990       GFAP（Glial Fibrillary Acidic Protein）膠質(zhì)纖維酸性蛋白（抗原）               0.5mg/6501mg/1100                         

QY-04240       MMP-1(matrix metalloproteinases-1)基質(zhì)金屬蛋白酶-1（抗原）            0.5mg/6501mg/1100                         

QY-04120       MMP-2(Collagenase IV /Gelatinase A/Metallo proteinase-2)基質(zhì)金屬蛋白酶-2(多肽抗原)              0.5mg/6501mg/1100                         

QY-04130       MMP-3(matrix metalloproteinase-3/Transin-1/SL-1/Stromelysin-1 precursor)基質(zhì)金屬蛋白酶-3(抗原)         0.5mg/6501mg/1100                         

QY-04230       MMP-7(Matrilysin/matrix metalloproteinases-7)基質(zhì)金屬蛋白酶-7(抗原)         0.5mg/6501mg/1100                         

QY-04140       MMP-14(Matrix metalloproteinase-14)金屬基質(zhì)蛋白酶-14               0.5mg/6501mg/1100                         

QY-02010       GFRα-1（GDNF family receptor alpha-1）GDNF家族受體α-1（抗原）            0.5mg/6501mg/1100                          【AGER（Advanced glycosylation end product-specific receptor）晚期糖基化終末產(chǎn)物特異性受體(抗原）】

QY-03510       GLUT2(Glucose transporter type 2）葡萄糖轉(zhuǎn)運蛋白2（抗原）            0.5mg/6501mg/1100                         

QY-01680       GFRA4 ( Persephin receptor ) (GFR receptor alpha 4)GDNF家族受體α-4（抗原）             0.5mg/6501mg/1100                           

QY-02050       GHRF (GHRH)生長激素釋放激素（因子）（抗原）         0.5mg/6501mg/1100                         

QY-08000       ANGPTL1/ANG-1 (Angiopoietin-like Protein 1)血管位蛋白樣1/血管生成素樣蛋白-1抗原           0.5mg/6501mg/1100                         

QY-03840       GLUT4(Glucose transporter type 4）葡萄糖轉(zhuǎn)運蛋白4（抗原）            0.5mg/6501mg/1100                         

QY-00980       GIP （Gastric Inhibitory polypeptide）胃泌素抑制肽（抗原）               0.5mg/6501mg/1100                         

QY-02080       GLP-2（Glucagon-like peptide-2）胰高血糖素樣肽-2（多肽抗原）               0.5mg/6501mg/1200                         

QY-01940       GRP94 （gp96）94kDa 糖調(diào)節(jié)蛋白（抗原）          0.5mg/6501mg/1100                         

QY-03480       G Protein(Guanine nucleotide-binding regulatory protein)G蛋白（鳥苷酸結(jié)合蛋白）（抗原）              0.5mg/6501mg/1100                         

QY-02520       GR (Glucocorticoid receptor)糖皮質(zhì)激素受體 多肽          0.5mg/6501mg/1100                         

QY-00230       GSK-3β(NT) (Glycogen Synthase Kinase-3β)糖原合酶激酶-3β（抗原）           0.5mg/6501mg/1100                         

QY-03410       CKR-L2（ G protein-coupled receptor-2 ）G蛋白偶聯(lián)受體-2(抗原)             0.5mg/6501mg/1100                         

QY-00280       GSK-3β, (Glycogen Synthase Kinase-3)葡萄糖合成激酶-3（抗原）             0.5mg/6501mg/1100                         

QY-01360       GTP-CH-1三磷酸鳥苷環(huán)水解酶（抗原）         0.5mg/6501mg/1100                         

QY-03440       H5N1-M2（Avian influenza Matrix Protein-2）H5N1流感病毒M2型（抗原）              0.5mg/6501mg/1100                         

QY-02210       HCV-Core丙型肝炎病毒-C區(qū)（多肽）             1mg/7002mg/1300                            【AGER（Advanced glycosylation end product-specific receptor）晚期糖基化終末產(chǎn)物特異性受體(抗原）】

QY-02180       HCV-NS1丙型肝炎病毒-NS1（抗原）              0.5mg/6501mg/1100                         

QY-02190       HCV-NS3丙型肝炎病毒-NS3（抗原）              0.5mg/10001mg/1800                       

QY-02130       HCV-NS4a丙型肝炎病毒-NS4a（抗原）           0.5mg/10001mg/1800                       

QY-02120       HEV戊型肝炎病毒（抗原）               0.5mg/6501mg/1100